Tower Research Capital LLC (TRC) - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 70 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 1.5%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$114,970
-9.3%
3,636
+17.0%
0.00%0.0%
Q2 2023$126,745
+58578.2%
3,108
-46.3%
0.00%
-42.9%
Q1 2023$216
+87.8%
5,793
+75.5%
0.01%
+40.0%
Q4 2022$115
-100.0%
3,300
-91.0%
0.01%
-84.8%
Q3 2022$2,048,000
+182.1%
36,596
+160.9%
0.03%
+106.2%
Q2 2022$726,000
+476.2%
14,029
+707.7%
0.02%
+1500.0%
Q1 2022$126,000
-78.7%
1,737
-65.4%
0.00%
-90.0%
Q4 2021$592,000
+66.8%
5,013
+89.5%
0.01%
+11.1%
Q3 2021$355,000
-21.6%
2,645
-5.4%
0.01%
-25.0%
Q2 2021$453,000
-88.0%
2,796
-94.1%
0.01%
-81.2%
Q1 2021$3,786,000
+11731.2%
47,178
+8034.1%
0.06%
+6300.0%
Q4 2020$32,000
-73.3%
580
-90.5%
0.00%0.0%
Q3 2020$120,000
+57.9%
6,074
+68.4%
0.00%
-66.7%
Q2 2020$76,0003,606
+23940.0%
0.00%
Q1 2020$0
-100.0%
15
-99.0%
0.00%
-100.0%
Q3 2019$19,000
-87.2%
1,444
-84.1%
0.00%
-90.0%
Q2 2019$149,000
+7350.0%
9,078
+7465.0%
0.01%
Q1 2019$2,000
-97.1%
120
-95.1%
0.00%
-100.0%
Q3 2018$70,000
+75.0%
2,449
+30.3%
0.01%
+66.7%
Q1 2018$40,000
-42.9%
1,879
-33.0%
0.00%
-50.0%
Q3 2017$70,0002,8060.01%
Q2 2017$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q4 2016$27,000
-60.9%
2,046
-49.3%
0.00%
-57.1%
Q3 2016$69,000
+392.9%
4,032
+529.0%
0.01%
+600.0%
Q2 2016$14,0006410.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders